Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Plans Move Back To More Generalist Inspectorate
Oct 22 2025
•
By
Sarah Karlin-Smith
and
Derrick Gingery
The FDA's inspectorate is set to revert back to a more generalist team.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Compliance
More from Drug Safety